BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/18/2024 11:53:42 AM | Browse: 52 | Download: 167
 |
Received |
|
2024-02-28 15:48 |
 |
Peer-Review Started |
|
2024-02-28 15:48 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-04-24 04:44 |
 |
Revised |
|
2024-05-06 16:04 |
 |
Second Decision |
|
2024-06-13 02:42 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-06-13 06:14 |
 |
Articles in Press |
|
2024-06-13 06:14 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-07-08 03:41 |
 |
Publish the Manuscript Online |
|
2024-09-18 11:53 |
ISSN |
1948-9366 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Editorial |
Article Title |
Gastric cancer liver metastasis will reduce the efficacy of immunotherapy
|
Manuscript Source |
Invited Manuscript |
All Author List |
Liang Wang, Shan-Shan Liu, Sheng-Mei Zhang, Xiao-Qian Chen, Tao Huang, Rong Tian, Ya-Qi Zhao, Zhou Chen and Cai-Rang Xianba |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
2021 Key topic of Qinghai Provincial Health system – Guiding plan topic |
2021-WJZDX-43 |
|
Corresponding Author |
Liang Wang, PhD, Lecturer, Department of Gastrointestinal Oncology Surgery, Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, No. 29 Tongren Road, Xining 810000, Qinghai Province, China. wangliang19911128@163.com |
Key Words |
Immune checkpoint inhibitors; Gastric cancer; Gastric cancer with liver metastasis; Immunotherapy; Liver immune tolerance |
Core Tip |
Immunotherapy has found extensive application in the clinical management of advanced gastric cancer (GC), yielding notable clinical outcomes. In the context of advanced GC with liver metastasis, immunotherapy fails to elicit the desired response owing to the presence of hepatic immune tolerance mechanisms and the compromised physical condition of patients, leading to a reduction in immune response rates. Therefore, liver metastases may be associated with a lower likelihood of immunotherapy success in GC patients. Enhancing the response to immunotherapy in GC patients with liver metastases involves overcoming liver immune tolerance mechanisms and their adverse effects. |
Publish Date |
2024-09-18 11:53 |
Citation |
<p>Wang L, Liu SS, Zhang SM, Chen XQ, Huang T, Tian R, Zhao YQ, Chen Z, Xianba CR. Gastric cancer liver metastasis will reduce the efficacy of immunotherapy. <i>World J Gastrointest Surg</i> 2024; 16(9): 2760-2764</p> |
URL |
https://www.wjgnet.com/1948-9366/full/v16/i9/2760.htm |
DOI |
https://dx.doi.org/10.4240/wjgs.v16.i9.2760 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345